Nanoparticles in practice for molecular-imaging applications: An overview
Source abstract
Abstract
Unlabelled Nanoparticles (NPs) are playing a progressively more significant role in multimodal and multifunctional molecular imaging. The agents like Superparamagnetic iron oxide (SPIO), manganese oxide (MnO), gold NPs/nanorods and quantum dots (QDs) possess specific properties like paramagnetism, superparamagnetism, surface plasmon resonance (SPR) and photoluminescence respectively. These specific properties make them able for single/multi-modal and single/multi-functional molecular imaging. NPs generally have nanomolar or micromolar sensitivity range and can be detected via imaging instrumentation. The distinctive characteristics of these NPs make them suitable for imaging, therapy and delivery of drugs. Multifunctional nanoparticles (MNPs) can be produced through either modification of shell or surface or by attaching an affinity ligand to the nanoparticles. They are utilized for targeted imaging by magnetic resonance imaging (MRI), single photon emission computed tomography (SPECT), positron emission tomography (PET), computed tomography (CT), photo acoustic imaging (PAI), two photon or fluorescent imaging and ultra sound etc. Toxicity factor of NPs is also a very important concern and toxic effect should be eliminated. First generation NPs have been designed, developed and tested in living subjects and few of them are already in clinical use. In near future, molecular imaging will get advanced with multimodality and multifunctionality to detect diseases like cancer, neurodegenerative diseases, cardiac diseases, inflammation, stroke, atherosclerosis and many others in their early stages. In the current review, we discussed single/multifunctional nanoparticles along with molecular imaging modalities. Statement of significance The present article intends to reveal recent avenues for nanomaterials in multimodal and multifunctional molecular imaging through a review of pertinent literatures. The topic emphasises on the distinctive characteristics of nanomaterial which makes them, suitable for biomedical imaging, therapy and delivery of drugs. This review is more informative of indicative technologies which will be helpful in a way to plan, understand and lead the nanotechnology related work.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Nanoplatforms for cancer theranostics · Cancer Research and Treatment
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. Applying magnetic resonance imaging to structural and functional brain research10.1166/jnsne.2013.1032 ↗
2. Molecular imaging with nanoparticles: giant roles for dwarf actors10.1007/s00418-008-0511-y ↗
3. A clearer vision for in vivo imaging10.1038/86684 ↗
4. Weissleder · 2010
5. Photoacoustic tomography: in vivo imaging from organelles to organs10.1126/science.1216210 ↗
6. New technologies for human cancer imaging10.1200/JCO.2007.14.3065 ↗
7. Molecular imaging of cardiovascular disease10.1161/CIRCULATIONAHA.106.647164 ↗
8. Asbury · 2011
9. Nanomaterials for X-ray imaging: gold nanoparticle enhancement of X-ray scatter imaging of hepatocellular carcinoma10.1021/nl200858y ↗
10. Novel trimethyl lock based enzyme switch for the self-assembly and disassembly of gold nanoparticles10.1039/b9nj00776h ↗
11. Using 915nm laser excited Tm3+/Er3+/Ho3+-doped NaYbF4 upconversion nanoparticles for in vitro and deeper in vivo bioimaging without overheating irradiation10.1021/nn200110j ↗
12. A novel estrogen receptor intramolecular folding-based titratable transgene expression system10.1038/mt.2009.171 ↗
13. Stem cell-mediated accelerated bone healing observed with in vivo molecular and small animal imaging technologies in a model of skeletal injury10.1002/jor.20736 ↗
14. Visualization of telomerase reverse transcriptase (hTERT) promoter activity using a trimodality fusion reporter construct
15. Single-phase Dy2O3: Tb3+ nanocrystals as dual-modal contrast agent for high field magnetic resonance and optical imaging10.1021/cm2003066 ↗
16. Manganese doped iron oxide theranostic nanoparticles for combined T1 magnetic resonance imaging and photothermal therapy10.1021/am5080453 ↗
17. Mn2+-doped silica nanoparticles for hepatocyte-targeted detection of liver cancer in T1-weighted MRI10.1016/j.biomaterials.2013.08.009 ↗
18. Multifunctional uniform nanoparticles composed of a magnetite nanocrystal core and a mesoporous silica shell for magnetic resonance and fluorescence imaging and for drug delivery10.1002/anie.200802469 ↗
19. Multifunctional iron oxide nanoparticles for diagnostics, therapy and macromolecule delivery10.7150/thno.4827 ↗
20. Multiwavelength photoacoustic imaging and plasmon resonance coupling of gold nanoparticles for selective detection of cancer10.1021/nl802929u ↗
21. Silica-coating and hydrophobation of CTAB-stabilized gold nanorods10.1021/cm060293g ↗
22. Gold nanorods for ovarian cancer detection with photoacoustic imaging and resection guidance via Raman imaging in living mice10.1021/nn304347g ↗
23. Selective photothermal therapy for breast cancer with targeting peptide modified gold nanorods10.1039/c2dt31227a ↗
24. Optical nano-imaging of gate-tunable graphene plasmons10.1038/nature11254 ↗
25. Carbon nanotubes as photoacoustic molecular imaging agents in living mice10.1038/nnano.2008.231 ↗
26. Design and characterization of lysine cross-linked mercapto-acid biocompatible quantum dots10.1021/cm051393+ ↗
27. Encapsulation of single quantum dots with mesoporous silica10.1007/s10439-009-9660-y ↗
28. Bright, non-blinking, and less-cytotoxic SiO2 beads with multiple CdSe/ZnS nanocrystals10.1039/c002243h ↗
29. Recent advance of biological molecular imaging based on lanthanide-doped upconversion-luminescent nanomaterials10.3390/nano4010129 ↗
30. 18F labeled nanoparticles for in vivo PET-CT imaging10.1021/bc8004649 ↗
31. 89Zr-labeled dextran nanoparticles allow in vivo macrophage imaging10.1021/bc200405d ↗
32. PEG modified BaGdF5: Yb/Er nanoprobes for multi-modal upconversion fluorescent, in vivo X-ray computed tomography and biomagnetic imaging10.1016/j.biomaterials.2012.09.019 ↗
33. Bimodal optical diagnostics of oral cancer based on Rose Bengal conjugated gold nanorod platform10.1016/j.biomaterials.2013.02.012 ↗
34. A, highly selective, cell-permeable fluorescent nanoprobe for ratiometric detection and imaging of peroxynitrite in living cells10.1002/chem.201100148 ↗
35. Aptamer-modified magnetic nanoprobe for molecular MR imaging of VEGFR2 on angiogenic vasculature10.1186/1556-276X-8-399 ↗
36. Iodine-125 radiolabeling of silver nanoparticles for in vivo SPECT imaging
37. Multifunctional nanomesoporous materials with upconversion (in vivo) and downconversion (in vitro) luminescence imaging based on mesoporous capping UCNPs and linking lanthanide complexes10.1039/C4NR04258A ↗
38. Molecular imaging in the era of personalized medicine10.4132/jptm.2014.10.24 ↗
39. Synthesis, characterization, and application of core-shell Co0.16Fe2.84O4@NaYF4(Yb, Er) and Fe3O4@NaYF4(Yb, Tm) nanoparticle as trimodal (MRI, PET/SPECT, and optical) imaging agents10.1021/acs.bioconjchem.5b00338 ↗
40. Molecular aspects of magnetic resonance imaging and spectroscopy10.1016/S0098-2997(99)00007-2 ↗
41. Enzyme-responsive multifunctional magnetic nanoparticles for tumor intracellular drug delivery and imaging10.1002/asia.201000905 ↗
42. HSA coated MnO nanoparticles with prominent MRI contrast for tumor imaging10.1039/c0cc01041c ↗
43. Preparation of biodegradable iron oxide nanoparticles with gelatin for magnetic resonance imaging10.2492/inflammregen.34.045 ↗
44. Superparamagnetic iron oxide nanoparticles stabilized by alginate: pharmacokinetics, tissue distribution, and applications in detecting liver cancers10.1016/j.ijpharm.2007.11.036 ↗
45. Magnetite albumin microspheres: a new MR contrast material10.2214/ajr.148.2.399 ↗
46. Albumin-based nanoparticles as magnetic resonance contrast agents: I. Concept, first syntheses and characterisation10.1007/s00418-010-0676-z ↗
47. Compartmentalization of a gadolinium complex in the apoferritin cavity: a route to obtain high relaxivity contrast agents for magnetic resonance imaging10.1002/1521-3773(20020315)41:6<1017::AID-ANIE1017>3.0.CO;2-P ↗
48. Molecular imaging: current status and emerging strategies10.1016/j.crad.2010.03.011 ↗
49. Lectin-conjugated Fe2O3@Au core@shell nanoparticles as dual mode contrast agents for in vivo detection of tumor10.1021/mp400456j ↗
50. Antibiofouling polymer-coated gold nanoparticles as a contrast agent for in vivo X-ray computed tomography imaging10.1021/ja071471p ↗
51. Anti-CD4-targeted gold nanoparticles induce specific contrast enhancement of peripheral lymph nodes in X-ray computed tomography of live mice10.1021/nl101019s ↗
52. Micro-CT enables microlocalisation and quantification of Her2-targeted gold nanoparticles within tumour regions
53. Bombesin functionalized gold nanoparticles show in vitro and in vivo cancer receptor specificity10.1073/pnas.1002143107 ↗
54. Targeted gold nanoparticles enable molecular CT imaging of cancer: an in vivo study
55. An X-ray computed tomography imaging agent based on long-circulating bismuth sulphide nanoparticles10.1038/nmat1571 ↗
56. Large-scale synthesis of bioinert tantalum oxide nanoparticles for X-ray computed tomography imaging and bimodal image-guided sentinel lymph node mapping10.1021/ja200120k ↗
57. Gadolinium chelate coated gold nanoparticles as contrast agents for both X-ray computed tomography and magnetic resonance imaging10.1021/ja078176p ↗
58. Chitosan-based systems for molecular imaging10.1016/j.addr.2009.09.007 ↗
59. The role of transrectal ultrasound-guided biopsy-based staging, preoperative serum prostate-specific antigen, and biopsy Gleason score in prediction of final pathologic diagnosis in prostate cancer.10.1016/S0090-4295(99)80195-2 ↗
60. Diagnosis of subepithelial tumors in the upper gastrointestinal tract by endoscopic ultrasonography10.4329/wjr.v2.i8.289 ↗
61. Rapid transformation of protein-caged nanomaterials into microbubbles as bimodal imaging agent10.1021/nn300768d ↗
62. Liver-specific and echogenic hyaluronic acid nanoparticles facilitating liver cancer discrimination10.1002/adfm.201301131 ↗
63. PET/NIRF/MRI triple functional iron oxide nanoparticles10.1016/j.biomaterials.2010.01.010 ↗
64. Positron emission tomography provides molecular imaging of biological processes10.1073/pnas.97.16.9226 ↗
65. Optical and multimodality molecular imaging insights into atherosclerosis10.1161/ATVBAHA.108.165530 ↗
66. Tumor-homing glycol chitosan-based optical/PET dual imaging nanoprobe for cancer diagnosis10.1021/bc500020g ↗
67. Bimodal magnetic-fluorescent probes for bioimaging10.1002/jemt.20912 ↗
68. Scanning time-domain optical mammography: detection and characterization of breast tumors in vivo10.1177/153303460500400503 ↗
69. Tumor targeting chitosan nanoparticles for dual-modality optical/MR cancer imaging10.1021/bc900408z ↗
70. Oleyl-chitosan nanoparticles based on a dual probe for optical/MR imaging in vivo10.1021/bc100241a ↗
71. High resolution optical imaging of epithelial and neuronal cells
72. UPAR-targeted optical imaging contrasts as theranostic agents for tumor margin detection10.7150/thno.7409 ↗
73. Iron BSUC-C. Rapid pharmacokinetic and biodistribution studies using cholorotoxin-conjugated iron oxide nanoparticles: a novel non-radioactive method, 2010
74. Heparin-coated gold nanoparticles for liver-Specific CT imaging10.1002/chem.200902344 ↗
75. Dual-functional alginic acid hybrid nanospheres for cell imaging and drug delivery10.1002/smll.200801375 ↗
76. Synthesis, characterization, and in vivo diagnostic applications of hyaluronic acid immobilized gold nanoprobes10.1016/j.biomaterials.2008.08.038 ↗
77. The use of nanocrystals in biological detection10.1038/nbt927 ↗
78. In vivo molecular and cellular imaging with quantum dots10.1016/j.copbio.2004.11.003 ↗
79. Quantum dot bioconjugates for imaging, labelling and sensing10.1038/nmat1390 ↗
80. Quantum dot-encoded mesoporous beads with high brightness and uniformity: rapid readout using flow cytometry10.1021/ac0354600 ↗
81. Quantum-dot-tagged microbeads for multiplexed optical coding of biomolecules10.1038/90228 ↗
82. Semiconductor nanocrystals as fluorescent biological labels10.1126/science.281.5385.2013 ↗
83. Fluorescent CdSe/ZnS nanocrystal-peptide conjugates for long-term, nontoxic imaging and nuclear targeting in living cells10.1021/nl049170q ↗
84. Emerging imaging techniques10.1161/01.RES.0000216870.73358.d9 ↗
85. Direct synthesis of aqueous quantum dots through 4, 4′-bipyridine-based twin ligand strategy10.1021/ic202252m ↗
86. Avidin: a natural bridge for quantum dot-antibody conjugates10.1021/ja0125570 ↗
87. Targeting cell surface receptors with ligand-conjugated nanocrystals10.1021/ja003486s ↗
88. CdSe/ZnS-labeled carboxymethyl chitosan as a bioprobe for live cell imaging10.1039/b509781a ↗
89. Bioactivation and cell targeting of semiconductor CdSe/ZnS nanocrystals with phytochelatin-related peptides10.1021/ja031691c ↗
90. Probing synaptic signaling with quantum dots10.2976/1.2735016/10.2976/1 ↗
91. Hydroxylated quantum dots as luminescent probes for in situ hybridization10.1021/ja0058334 ↗
92. In vitro diagnostic prospects of nanoparticles10.1016/j.cca.2009.01.016 ↗
93. Quantum dots as a novel immunofluorescent detection system for Cryptosporidium parvum and Giardia lamblia10.1128/AEM.70.1.597-598.2004 ↗
94. High-sensitivity bacterial detection using biotin-tagged phage and quantum-dot nanocomplexes10.1073/pnas.0601211103 ↗
95. Multiplexed toxin analysis using four colors of quantum dot fluororeagents10.1021/ac035083r ↗
96. Metallic nanoparticles bioassay for Enterobacter cloacae P99 β-lactamase activity and inhibitor screening10.1039/b926909f ↗
97. Polymer-encapsulated organic nanoparticles for fluorescence and photoacoustic imaging10.1039/C4CS00014E ↗
98. Annexin A5-conjugated polymeric micelles for dual SPECT and optical detection of apoptosis10.2967/jnumed.110.083220 ↗
99. Clinical spectrum of secondary Parkinsonism in childhood: a reversible disorder10.1016/0887-8994(94)90045-0 ↗
100. Paramagnetic ultrasmall gadolinium oxide nanoparticles as advanced T1 MRI contrast agent: account for large longitudinal relaxivity, optimal particle diameter, and in vivo T1 MR images10.1021/nn900761s ↗